D. E. Shaw & Co., Inc. ODONATE THERAPEUTICS INC Transaction History

D. E. Shaw & Co., Inc.

  • $122 Billion
  • Q4 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
N/A
-374,195 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
N/A
140,855 Added 60.36%
374,195 $505,000
Q3 2021

Nov 15, 2021
SELL
N/A
-106,728 Reduced 31.38%
233,340 $679,000
Q2 2021

Aug 16, 2021
BUY
N/A
39,236 Added 13.04%
340,068 $1.19 Million
Q1 2021

May 17, 2021
BUY
N/A
149,732 Added 99.09%
300,832 $1.03 Million
Q4 2020

Feb 16, 2021
BUY
N/A
48,647 Added 47.48%
151,100 $2.9 Million
Q3 2020

Nov 16, 2020
BUY
N/A
1,378 Added 1.36%
102,453 $1.38 Million
Q2 2020

Aug 14, 2020
BUY
N/A
368 Added 0.37%
101,075 $4.28 Million
Q1 2020

May 15, 2020
SELL
N/A
-11,290 Reduced 10.08%
100,707 $2.78 Million
Q4 2019

Feb 14, 2020
BUY
N/A
41,913 Added 59.8%
111,997 $3.63 Million
Q3 2019

Nov 14, 2019
BUY
N/A
70,084 New
70,084 $1.82 Million
Q4 2018

Feb 14, 2019
SELL
N/A
-18,359 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
N/A
-2,423 Reduced 11.66%
18,359 $356,000
Q2 2018

Aug 14, 2018
SELL
N/A
-15,409 Reduced 42.58%
20,782 $459,000
Q1 2018

May 15, 2018
BUY
N/A
36,191 New
36,191 $767,000
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email